Opioid Drugs Market

Opioid Drugs Market, by Drug Type (Codeine, Fentanyl, Morphine, Hydrocodone, Oxycodone, and Others), by Application (Analgesia, Cough Suppression, and Diarrhea Suppression), by Route of Administration (Oral, Topical, Parenteral, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Opioids are substances that act on opioid receptors to produce morphine-like effects. Medically, they are primarily used for pain relief, including anesthesia. Other medical uses include suppression of diarrhea, replacement therapy for opioid use disorder, reversing opioid overdose, and suppressing cough. One of the first opioid drugs, ‘morphine’, was developed in 1803. Opioid drugs act on the opioid receptors present in the central and peripheral nervous systems, thus providing relief from pain. Opioids are administered in the form of oral pills, parenteral liquids, patches, or lozenges. There are different types of prescription opioids available, such as fentanyl, oxycodone, morphine, codeine, oxymorphone, and hydrocodone, which are prescribed by physicians for mainly treating pain.

Market Dynamics

The key market players are focused on organic growth strategies such as product launches and approval, and this is expected to drive market growth for the forecast period. Moreover, the growing geriatric population globally is expected to increase the usage of opioids, as elderly people are at high risk of chronic diseases such as cardiovascular diseases, arthritis, and cancer due to the high comorbid conditions. Thus, the rising prevalence of old people is expected to drive market growth. In addition, the increasing prevalence of chronic diseases such as cancer, chronic pain due to arthritis, lower back pain, fibromyalgia, and postsurgical pain is also expected to increase the usage of opioids as pain relieving agents, which is expected to drive market growth for the forecast period. For instance, as per the factsheet published by the Center for Disease Control and Prevention (CDC) in October 2021, about 1 in 4 U.S. adults (23.7%), or about 58.5 million people, have doctor-diagnosed arthritis, and this is expected to reach 78 million by 2045.

Key features of the study:

• This report provides an in-depth analysis of the global opioid drugs market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global opioid drugs market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Endo International plc, Lupin Limited, Cadila Healthcare Limited, Purdue Pharma L.P., AbbVie Inc., Fresenius Kabi, Mallinckrodt Pharmaceuticals, Pfizer Inc., Rhodes Pharmaceuticals L.P., Sun Pharmaceutical Industries Limited, Nesher Pharmaceuticals (USA) LLC, Amneal Pharmaceuticals LLC, Trevena Inc., and Aurobindo Pharma Limited
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global opioid drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global opioid drugs market.

Opioid Drugs Market Detailed Segmentation:

• By Drug Class:
• Alkaloids

Morphine

Codeine

• Semisynthetic Opioids

Oxycodone

Hydrocodone

Hydromorphone

• Synthetic Opioids

Fentanyl

Alfentanil

• By Application:
• Analgesia
• Cough Suppression
• Diarrhea Suppression
• By Route of Administration:
• Oral
• Topical
• Parenteral
• Others (Intramuscular, etc.)
• By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• By Region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa
• Company Profiles
• Teva Pharmaceutical Industries Ltd.
• Johnson & Johnson
• Endo International plc
• Lupin Limited
• Cadila Healthcare Limited
• Purdue Pharma L.P.
• AbbVie Inc.
• Fresenius Kabi
• Mallinckrodt Pharmaceuticals
• Pfizer Inc.
• Rhodes Pharmaceuticals L.P.
• Sun Pharmaceutical Industries Limited
• Nesher Pharmaceuticals (USA) LLC
• Amneal Pharmaceuticals LLC
• Trevena Inc.
• Aurobindo Pharma Limited